Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market Trends

Statistics for the 2023 & 2024 Asia-Pacific Kidney Cancer Therapeutics & Diagnostics market trends, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Kidney Cancer Therapeutics & Diagnostics trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Industry

This section covers the major market trends shaping the APAC Kidney Cancer Therapeutics & Diagnostics Market according to our research experts:

Renal Cancer Carcinoma is Expected to be the Largest Growing Segment in the Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market

Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule in the kidney that transport primary urine. It is the most common type of kidney cancer. Renal cell carcinoma mainly affects the population who are older, usually between ages 50 and 70. 

The factors that are driving the market that includes growing awareness among people about cancer, rising geriatric population, and rising incidence of renal cancer. As per Cancer Australia, in 2019, it was estimated that the age-standardized mortality rate due to kidney cancer was 3.3 deaths per 100,000 persons (4.7 for males and 2.1 for females) in Australia. The mortality rate for kidney cancer is expected to increase with age which shows a positive impact on the market. Thus, increasing cases of kidney cancer, the growing geriatric population along with that awareness about cancer are the major factors driving the segment and expected to do over the forecast period.

APAC kidney cancer key trend 1.png

Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)